A platelet-activating factor receptor antagonist protects against renal function deterioration in nephrotoxic nephritis.
Livio
M
M
Researcher of the National Research Council (CNR), University of Milan, Italy.
Macconi
D
D
Morigi
M
M
Orisio
S
S
Benigni
A
A
Patrono
C
C
Remuzzi
G
G
D000818:Animals; D005663:Furans / Q000494:pharmacology*; D005919:Glomerular Filtration Rate / Q000187:drug effects; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D008297:Male; D010972:Platelet Activating Factor / Q000502:physiology; D010980:Platelet Membrane Glycoproteins; D011507:Proteinuria / Q000188:drug therapy; D011817:Rabbits; D011956:Receptors, Cell Surface / Q000187:drug effects*; D043562:Receptors, G-Protein-Coupled
D005663:Furans; D010972:Platelet Activating Factor; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; C039351:platelet activating factor receptor; C047504:2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran